Viral variant but not host factors associate with SARS-CoV-2 viral kinetics
Lynda Stranix‐Chibanda(University of Zimbabwe), Carole L. Wallis(Lancet Laboratories), Maphoshane Nchabeleng(Sefako Makgatho Health Sciences University), Hong‐Van Tieu(New York Blood Center), Valeria D Cantos(Emory University), Leigh H. Fisher(Fred Hutch Cancer Center), April K. Randhawa(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Wadzanai Samaneka(University of Zimbabwe), Pavitra Roychoudhury(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lameck Chinula(University of North Carolina at Chapel Hill), Chishiba Kabengele, Catherine Yen(National Institutes of Health), Nicole Espy(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Brenda Hoagland(Fundação Oswaldo Cruz), William Brumskine(Aurum Institute), Khatija Ahmed(University of California, San Francisco), Edgar García, Marcelo Losso(UCLA Medical Center), Mmatsie Manentsa, Shannon Grant(Fred Hutch Cancer Center), Colleen F. Kelley(Emory University), Jorge Pinto(Universidade Federal de Minas Gerais), Amy Ward(Wellcome Centre for Infectious Diseases Research in Africa), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Pedro E. Cahn(Fundación Huésped), Joseph Makhema(Harvard University), Jennifer Hanke(Fred Hutch Cancer Center), Jorge A. Gallardo-Cartagena(National University of San Marcos), Lawrence Corey, William O. Hahn, Beatriz Grinsztejn, Alexander L. Greninger, Ollivier Hyrien, Craig Innes, Nadine Rouphael, Xiaohong Li, Muchaneta Bhondai-Mhuri, Shelly Ramirez(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Roma Chilengi, Javier R. Lama(Asociación Civil Impacta Salud y Educación)
Cited by 0
Related Papers
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
|The Lancet|2008|708
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
|New England Journal of Medicine|2013|586
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition
|New England Journal of Medicine|2021|557